Lazarex Cancer Foundation

Lazarex CARE Program: This program focuses on improving the outcome of cancer care for advanced stage cancer patients and the medically underserved by identifying FDA clinical trial options, providing assistance with out-of-pocked travel expenses for clinical trial participation and a travel companion if needed, and by facilitating community outreach and engagement. In 2023, we assisted 1236 patients with this program, an increase of 28% over 2022. We continue to increase racial and ethnic diversity of participants in this program, achieving 37%, while the national average in cancer clinical trials at about 5%. 30% of patients assisted came from households earning less than $25,000 annually.

Lazarex IMPACT Program: The goal of IMPACT is to generate a sustainable proof of concept action plan to transform the status quo of clinical trial recruitment, enrollment, retention, minority participation, completion, and translational science, most importantly providing equitable and timely access to cancer discovery for all patients. In 2023, IMPACT was in operation at Penn Abramson, UTSW, USOR, and MD Anderson Comprehensive Cancer Center. In 2023 we served 602 patients in this program, with 37% minority participation, and 25% from households earning less than $25,000 annually.

Lazarex Cancer Wellness Hub Program: Lazarex Cancer Wellness Hubs operated in Philadelphia through Drexel University and Penn Abramson, in Los Angeles through USC Norris, and in the San Francisco East Bay area in collaboration with Monument Crisis Center. The goal of the Lazarex Cancer Wellness Hub Program is to generate a replicable program that is place based, culturally appropriate, and community driven, that operates in at-risk communities of color across the continuum of cancer care to improve cancer health disparities and improve cancer health outcomes.